GlassScriptPhysician profile
Jenna L Cook
NPI 1891080362
$2,936.35
in general payments reported to CMS, 2019-2025
30 companies · $374 in 2025
The $374 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $26.12 · 2021: $245 · 2022: $639 · 2023: $836 · 2024: $557 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,669 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,668.53 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,460.20 | 2019-2025 | Qulipta, Vraylar, Ubrelvy |
| Astellas Pharma US INC | $286.56 | 2023-2025 | Veozah |
| Pfizer INC. | $187.47 | 2023-2024 | |
| Novo Nordisk INC | $183.89 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Biohaven Pharmaceutical Holding Company LTD. | $118.60 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $106.94 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.40 | 2021-2024 | Jardiance |
| Mayne Pharma Commercial LLC | $52.94 | 2025 | |
| Boston Scientific Corporation | $49.70 | 2024 | Watchman Flx |
| Lilly USA, LLC | $46.22 | 2022-2023 | Jardiance |
| Impulse Dynamics (USA) INC. | $38.88 | 2023 | Optimizer |
| Philips North America LLC | $35.54 | 2024 | (Ck7) Extended Holter |
| Hologic Sales and Service, LLC | $23.14 | 2024 | Acessa Provu System, Novasure |
| Biogen, INC. | $20.92 | 2025 | Zurzuvae |
| Organon LLC | $20.70 | 2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $20.30 | 2023 | Rexulti |
| Mylan Specialty L.P. | $20.05 | 2021 | |
| Nestle Healthcare Nutrition INC. | $19.46 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $18.57 | 2022 | |
| Supernus Pharmaceuticals, INC. | $18.06 | 2022 | |
| Sanofi Pasteur INC. | $17.57 | 2023 | |
| Duchesnay USA Incorporated | $16.97 | 2019 | |
| Medtronic, INC. | $15.30 | 2023 | Kyphon Express II Kyphopak Tray |
| Merck Sharp & Dohme LLC | $15.11 | 2023 | Vaxelis, Gardasil 9, Vaxneuvance |
| Exeltis, USA INC. | $14.64 | 2024 | Slynd |
| Astrazeneca Pharmaceuticals LP | $13.47 | 2024 | Farxiga |
| Amgen INC. | $13.30 | 2023 | Evenity, Prolia |
| Biohaven Pharmaceuticals, INC. | $13.19 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.21 | 2021 | |
| Therapeuticsmd, INC. | $12.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.